VRM
OGN icon

Vectors Research Management’s Organon & Co OGN Stock Holding History

Vectors Research Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-241
Closed -$8K – 369
2022
Q2 		$8K Buy
241
+6
+3% +$210 ﹤0.01% 394
2022
Q1 		$8K Sell
235
-1,321
-85% -$45.2K ﹤0.01% 380
2021
Q4 		$47K Sell
1,556
-21
-1% -$684 0.01% 264
2021
Q3 		$52K Buy
1,577
+45
+3% +$1.44K 0.01% 230
2021
Q2 		$46K Buy
+1,532
New +$50.4K 0.01% 245

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vectors Research Management's OGN Position: Q3 2022 in Review

Vectors Research Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 241 shares — an estimated $8K sold.

Vectors Research Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $52K in Q3 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Vectors Research Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Vectors Research Management sold 241 Organon & Co shares in Q3 2022, an estimated $8K.
  • Vectors Research Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Vectors Research Management's Organon & Co position peaked at $52K in Q3 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.